Kettunen is suspended from participating in all competitions and activities authorized and organized by IIHF or any IIHF Member National Association. The period of ineligibility amounts to four (4) years, commencing on 28 May 2018, ending on 27 May 2022.
The decision came as a result of Kettunen’s use of a Prohibited Substance according to section S1.2, Other Anabolic Agents (Non-specified Substances) of the World Anti-Doping Code 2017 Prohibited List.
Kettunen, who last participated as member of the Estonian national ice hockey team in the 2018 IIHF Ice Hockey World Championship Division I Group B, was asked to submit to doping control following Estonia’s game against Romania on 25 April. A lab analysis revealed that his A and the B-sample revealed the presence of Clenbuterol listed in the Prohibited List under S1.2, as an other Anabolic Agent.
On 28 May 2018, the IIHF notified the Player of the adverse analytical finding and that according to World Anti-Doping Code (Code) Article 7.9.1 he was immediately provisionally suspended.
The Prohibited Substance found in the Player’s sample is a Non-specified Substance (see introductory sentence of the Prohibited List 2017). The period of ineligibility to be imposed for the violation of Code Article 2.1 according to Code Article 10.2.1.1 therefore should be four years, unless the Player can establish that the anti-doping rule violation was not intentional in the sense of Code Article 10.2.3.
Despite Kettunen’s claim that his adverse analytical finding came from contaminated meat, the Disciplinary Board was of the opinion that the player was not able to produce sufficient evidence of this, and that a four-year suspension was still applicable.
The decision may be appealed to the Court of Arbitration for Sport.